Vericel Corp Ord (VCEL)
Interest coverage
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | -3,685 | -11,080 | -13,735 | -16,717 | -15,613 | -18,257 | -16,736 | -11,506 | -7,578 | 613 | 9,163 | 4,608 | 3,050 | -141 | -664 | -12,596 | -11,251 | -14,466 | -18,899 | -2,945 |
Interest expense (ttm) | US$ in thousands | 600 | 667 | 622 | 493 | 366 | 144 | 40 | 21 | 4 | 4 | 5 | 5 | 6 | 7 | 7 | 8 | 8 | -1,303 | -845 | -399 |
Interest coverage | -6.14 | -16.61 | -22.08 | -33.91 | -42.66 | -126.78 | -418.40 | -547.90 | -1,894.50 | 153.25 | 1,832.60 | 921.60 | 508.33 | -20.14 | -94.86 | -1,574.50 | -1,406.38 | — | — | — |
December 31, 2023 calculation
Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $-3,685K ÷ $600K
= -6.14
I'm sorry, but I currently do not have access to the specific financial data related to Vericel Corp's interest coverage for analysis. To provide a detailed and comprehensive analysis, I would need the actual numbers for interest expense and earnings before interest and taxes (EBIT) over the mentioned quarters. Kindly provide the data, and I will be able to assist you in analyzing Vericel Corp's interest coverage in a detailed manner.
Peer comparison
Dec 31, 2023
Company name
Symbol
Interest coverage
Vericel Corp Ord
VCEL
-6.14
Amgen Inc
AMGN
2.75
Bio-Techne Corp
TECH
12.91
Biogen Inc
BIIB
6.25
Gilead Sciences Inc
GILD
8.32
Halozyme Therapeutics Inc
HALO
19.56
Krystal Biotech Inc
KRYS
-2.70
Moderna Inc
MRNA
—
Neurocrine Biosciences Inc
NBIX
73.20
Regenxbio Inc
RGNX
-39.07
Repligen Corporation
RGEN
33.89